Skip to main content

A Salvage Trial of AR Inhibition with ADT and Apalutamide with Docetaxel followed by Radiation Therapy in Men with PSA Recurrent Prostate Cancer after Radical Prostatectomy (¿STARTAR¿)

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Janssen Pharmaceutica, Inc.

Start Date

March 8, 2018

End Date

February 28, 2023
 

Administered By

Duke Cancer Institute

Awarded By

Janssen Pharmaceutica, Inc.

Start Date

March 8, 2018

End Date

February 28, 2023